Opportunity Analysis and Industry Forecast,

Market Segmentation AGE GROUP 15 ‐ 24 years 25 ‐ 34 years 35 ‐ 44 years Above 44 years BY EDUCATION Less than high school High school graduate College graduate Other college degrees BY PRODUCT Drugs Devices Intrauterine Devices (IUDs)

Global contraceptives market generated a revenue of $28,175 million in 2015 and is estimated to reach $43,812 million by 2022, registering a CAGR of 6.4% during the analysis period. Contraception is a method of preventing pregnancy using drugs or a device. It is also known as birth control and fertility control. The devices or drugs used in contraception interfere with the normal process of sperm-ovum fertilization to prevent pregnancy. contraceptives Actual Market Value

Key Players The Female Health Company Mayer Laboratories Teva Pharmaceutical Industries Limited BioSante Pharmaceuticals Inc. Church & Dwight, Co. Merck & Co.

Key Benefits of Contraceptives Intrauterine (IUD) segment is projected to grow at a significant CAGR of 10.1% during the analysis period. Oral contraceptive drugs or pills was the leading segment in the overall contraceptive market, accounting for $16,997 million in 2015, and is projected to grow at a CAGR of 5.6% during the forecast period. Vaginal ring is estimated to grow at significant rate of 10.0% during the forecast period from 2016 to 2022.

Make An Inquiry About Report: enquiry/451 Get PDF Sample of Advance sample/451 sample/451

SUBSCRIBE CHANNEL FOLLOW US Thank You! For More Details Visit us at